GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shelter Pharma Ltd (BOM:543963) » Definitions » LT-Debt-to-Total-Asset

Shelter Pharma (BOM:543963) LT-Debt-to-Total-Asset : 0.02 (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Shelter Pharma LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Shelter Pharma's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.02.

Shelter Pharma's long-term debt to total assets ratio increased from Sep. 2023 (0.00) to Sep. 2024 (0.02). It may suggest that Shelter Pharma is progressively becoming more dependent on debt to grow their business.


Shelter Pharma LT-Debt-to-Total-Asset Historical Data

The historical data trend for Shelter Pharma's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shelter Pharma LT-Debt-to-Total-Asset Chart

Shelter Pharma Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
LT-Debt-to-Total-Asset
- - 0.01 0.02 0.02

Shelter Pharma Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial - 0.02 - 0.02 0.02

Shelter Pharma LT-Debt-to-Total-Asset Calculation

Shelter Pharma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )/Total Assets (A: Mar. 2024 )
=5.732/379.148
=0.02

Shelter Pharma's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )/Total Assets (Q: Sep. 2024 )
=10.142/429.787
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shelter Pharma  (BOM:543963) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Shelter Pharma LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Shelter Pharma's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Shelter Pharma Business Description

Traded in Other Exchanges
N/A
Address
Opp. MJ Library Ashram Road, 5th Floor, 501 Sakar 4, Paldi, Ellisbridge, Ahmedabad, GJ, IND, 380006
Shelter Pharma Ltd focuses in manufacturing herbal products with a well-built presence in Human Pharma as well as the Veterinary space. It is present in most of the non-critical segments of human and veterinary pharma through its well-spread portfolio. Its products include tablets, syrups, baby drops, barley water, oils, powders, ointments, etc.

Shelter Pharma Headlines

No Headlines